Impact of treatment approach on maternal and neonatal outcome in pregnant opioid‐maintained women
- 8 August 2011
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 26 (6) , 412-421
Abstract
Objective: The objective of this study is to compare maternal and neonatal outcome of opioid‐dependent women maintained on buprenorphine or methadone throughout pregnancy in a randomized double‐blind double‐dummy clinical trial (CT) with a comparison group undergoing a structured standard protocol (SP) at the Medical University of Vienna, Austria.Methods: One hundred and fourteen subjects were included in the analysis, with 77 in SP (n = 51 methadone, n = 26 buprenorphine), and 37 in CT (n = 19 methadone, n = 18 buprenorphine), comparing maternal concomitant consumption during third trimester, demographic birth data, duration of treatment for neonatal abstinence syndrome (NAS), morphine dose for NAS treatment and length of hospital stay (LOS).Results: Both study groups yielded healthy neonates with no significant demographic differences and equivalently low rates of positive maternal urine toxicologies. However, NAS parameters were significantly better in CT regarding total medication dose administered to neonates (p = 0.014) and LOS (p = 0.015). Superior results were achieved in buprenorphine compared with methadone‐exposed neonates regarding gestational age at birth (p = 0.003), birth weight (p = 0.011), total morphine dose administered (p = 0.008), NAS treatment duration (p = 0.008) and LOS (p = 0.001).Conclusions: Comparably favorable outcome for mothers and infants and efficacy and safety of opioid medications were shown in both treatment approaches. Neonatal care could benefit from transferring successful CT procedures into clinical practice. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 41 references indexed in Scilit:
- Neonatal Abstinence Syndrome after Methadone or Buprenorphine ExposureNew England Journal of Medicine, 2010
- Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: BuprenorphineJournal of Addictive Diseases, 2010
- Clinical Characteristics of Central European and North American Samples of Pregnant Women Screened for Opioid Agonist TreatmentEuropean Addiction Research, 2010
- Youth retention: Factors associated with treatment drop‐out from youth alcohol and other drug treatmentDrug and Alcohol Review, 2009
- Neonatal abstinence syndrome—postnatal ward versus neonatal unit managementEuropean Journal of Pediatrics, 2009
- Treatment of opioid-dependent pregnant women: Clinical and research issuesJournal of Substance Abuse Treatment, 2008
- The Opioid Dependent Mother and Newborn Dyad: Nonpharmacologic CareJournal of Addiction Medicine, 2008
- Effects of voucher‐based incentives on abstinence from cigarette smoking and fetal growth among pregnant womenAddiction, 2008
- Opiatabhängigkeit in der Schwangerschaft - Konsequenzen für das Neugeborene1 - Ergebnisse eines interdisziplinären Betreuungsmodells -Zeitschrift für Geburtshilfe und Neonatologie, 2001
- Maintenance therapy with synthetic opioids within a multidisciplinary program - A stabilizing necessity for pregnant opioid dependent womenArchives of Women's Mental Health, 1998